Literature DB >> 25794550

Interferon gamma, interleukin-6, and -17a levels were correlated with minimal hepatic encephalopathy in HBV patients.

Wei Li1, Ning Li, Rui Wang, Qunhui Li, Hao Wu.   

Abstract

BACKGROUND AND
OBJECTIVE: Cytokines have been reported to be involved in the cirrhosis and hepatic encephalopathy (HE). Many aspects on the correlation between minimal HE (MHE) and cytokine levels were still unclear.
METHODS: Two hundred eighty-nine HBV-infected cirrhotic patients were grouped: non MHE (n = 156), MHE (n = 98) and clinical HE (CHE, n = 213). Another 88 healthy volunteers were included as controls. Clinical and laboratory findings and levels of ten serum cytokines were analyzed.
RESULTS: All tested cytokines were significantly elevated in cirrhotic patients and patients with CHE compared with controls. Statistical analysis showed only IL-6, IFNγ and IL-17a were correlated MHE (all three p < 0.001). Multivariate regression analysis indicated that serum IL-6 and IL-17a levels were independent risk factors for MHE. Moreover, all patients with MHE had IL-17a levels higher than 49 pg/mL, whereas those without MHE had IL-17a levels lower than 49 pg/mL.
CONCLUSIONS: IL-6, IFNγ, and IL-17a were correlated with MHE in HBV-infected patients. Two independent risk factors (IL-6, IL-17a) for MHE were identified. Our findings pointed out the crucial roles of cytokines in MHE in HBV-infected patients.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25794550     DOI: 10.1007/s12072-015-9610-8

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  29 in total

1.  Expression of beta-chemokines and chemokine receptors in human fetal astrocyte and microglial co-cultures: potential role of chemokines in the developing CNS.

Authors:  P Rezaie; G Trillo-Pazos; I P Everall; D K Male
Journal:  Glia       Date:  2002-01       Impact factor: 7.452

2.  Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis.

Authors:  A Das; R K Dhiman; V A Saraswat; M Verma; S R Naik
Journal:  J Gastroenterol Hepatol       Date:  2001-05       Impact factor: 4.029

3.  Can serum cytokines predict hepatic cytokine expression in liver cirrhosis?

Authors:  Ying-Ying Yang
Journal:  J Chin Med Assoc       Date:  2011-11-01       Impact factor: 2.743

Review 4.  Characteristics of minimal hepatic encephalopathy.

Authors:  Piero Amodio; Sara Montagnese; Angelo Gatta; Marsha Y Morgan
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

5.  Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy.

Authors:  M Romero-Gómez; F Boza; M S García-Valdecasas; E García; J Aguilar-Reina
Journal:  Am J Gastroenterol       Date:  2001-09       Impact factor: 10.864

6.  Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

Authors:  Peter Ferenci; Alan Lockwood; Kevin Mullen; Ralph Tarter; Karin Weissenborn; Andres T Blei
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

7.  IL-1 or TNF receptor gene deletion delays onset of encephalopathy and attenuates brain edema in experimental acute liver failure.

Authors:  Chantal Bémeur; Hong Qu; Paul Desjardins; Roger F Butterworth
Journal:  Neurochem Int       Date:  2009-11-17       Impact factor: 3.921

Review 8.  Role of the cytokines in the neuroendocrine-immune system axis.

Authors:  B L Spangelo; W C Gorospe
Journal:  Front Neuroendocrinol       Date:  1995-01       Impact factor: 8.606

9.  Detection of interleukin-1 and interleukin-6 in adult rat brain, following mechanical injury, by in vivo microdialysis: evidence of a role for microglia in cytokine production.

Authors:  M N Woodroofe; G S Sarna; M Wadhwa; G M Hayes; A J Loughlin; A Tinker; M L Cuzner
Journal:  J Neuroimmunol       Date:  1991-09       Impact factor: 3.478

10.  Oligoclonal myelin-reactive T-cell infiltrates derived from multiple sclerosis lesions are enriched in Th17 cells.

Authors:  Monica Montes; Xin Zhang; Laureline Berthelot; David-Axel Laplaud; Sophie Brouard; Jianping Jin; Sarah Rogan; Diane Armao; Valerie Jewells; Jean-Paul Soulillou; Silva Markovic-Plese
Journal:  Clin Immunol       Date:  2008-11-05       Impact factor: 3.969

View more
  6 in total

Review 1.  Cytokines and chemokines involved in the defense reaction against HIV-1 and hepatitis B virus: isn't it time to use a standardized nomenclature of the involved mediators?

Authors:  Lutz G Gürtler
Journal:  Virus Genes       Date:  2019-12-17       Impact factor: 2.332

2.  Glycosylation patterns and PHA-E-associated glycoprotein profiling associated with early hepatic encephalopathy in Chinese hepatocellular carcinoma patients.

Authors:  Tian-Hua Liu; Deng-He Liu; Cui-Ju Mo; Lu Sun; Xiao-Xia Liu; Wei Li; Shu Zhang; Yin-Kun Liu; Kun Guo
Journal:  Am J Transl Res       Date:  2016-10-15       Impact factor: 4.060

3.  Fecal microbiota transplantation prevents hepatic encephalopathy in rats with carbon tetrachloride-induced acute hepatic dysfunction.

Authors:  Wei-Wei Wang; Yu Zhang; Xiao-Bing Huang; Nan You; Lu Zheng; Jing Li
Journal:  World J Gastroenterol       Date:  2017-10-14       Impact factor: 5.742

Review 4.  Cognition-tracking-based strategies for diagnosis and treatment of minimal hepatic encephalopathy.

Authors:  Weijia Han; Huanqian Zhang; Ying Han; Zhongping Duan
Journal:  Metab Brain Dis       Date:  2020-06-03       Impact factor: 3.584

5.  KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2020-01-10

Review 6.  Current approach to treatment of minimal hepatic encephalopathy in patients with liver cirrhosis.

Authors:  Segundo Moran; Marlene López-Sánchez; María Del Pilar Milke-García; Gustavo Rodríguez-Leal
Journal:  World J Gastroenterol       Date:  2021-06-14       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.